Blood tester, a non-invasive screening option Shield - Brand name or equal will be considered.

The Indian Health Service (IHS) Phoenix Area Office is soliciting written quotations for 120 new Shield™ blood‑tester units (or equal) – a non‑invasive, FDA‑approved colorectal cancer screening device – with a base purchase plus a four‑year service contract (approximately 20 units per year). All equipment must be new, sourced from an OEM‑authorized dealer, distributor, or reseller, and must include the manufacturer’s warranty and a copy of the authorized‑distributor letter. Quotes must incorporate shipping (FOB Destination) in the total price, cannot be split, and must be submitted by 05 Oct 2026, 5:00 PM ET. Offerors must be SAM‑registered, may use the IPP system (or provide a burden justification), and must comply with the listed FAR and HHSAR clauses, including the required representations, certifications, and invoicing procedures (monthly electronic invoices with line‑item detail). Evaluation will consider price (including all options), technical compliance, product acceptance, delivery, and past performance.

Notice ID

e9ccf2f83417437ab8a8998fb8320c6a

Solicitation Number

IHS1522255v2

NAICS Code

339112

Classification Code

6515